SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-17-013159
Filing Date
2017-11-14
Accepted
2017-11-14 15:26:45
Documents
65
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 655731
2 ex31-1.htm EX-31.1 14881
3 ex31-2.htm EX-31.2 16328
4 ex32-1.htm EX-32.1 7089
5 ex32-2.htm EX-32.2 7049
6 image_002.jpg GRAPHIC 19129
  Complete submission text file 0001493152-17-013159.txt   3653479

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE heb-20170930.xml EX-101.INS 639641
8 XBRL SCHEMA FILE heb-20170930.xsd EX-101.SCH 50375
9 XBRL CALCULATION FILE heb-20170930_cal.xml EX-101.CAL 48475
10 XBRL DEFINITION FILE heb-20170930_def.xml EX-101.DEF 163590
11 XBRL LABEL FILE heb-20170930_lab.xml EX-101.LAB 340746
12 XBRL PRESENTATION FILE heb-20170930_pre.xml EX-101.PRE 235004
Mailing Address 1617 JFK BLVD, SUITE #500 ONE PENN CENTER PHILADELPHIA PA 19103
Business Address 1617 JFK BLVD, SUITE #500 ONE PENN CENTER PHILADELPHIA PA 19103 215-988-0080
HEMISPHERX BIOPHARMA INC (Filer) CIK: 0000946644 (see all company filings)

IRS No.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-27072 | Film No.: 171201024
SIC: 2836 Biological Products, (No Diagnostic Substances)